Quick ReadPlain-language overview · read this first
SÜSS MicroTec is a German semiconductor equipment company. The report’s stance is clear: the company is not weak, but the current price is too expensive. The rating is Watch, and chasing the stock is not recommended.
It does not sell chips. It sells manufacturing equipment used by chipmakers, including tools for advanced packaging and photomask processing. In other words, others make chips; it makes the machines used to make chips. The issue is that this business mainly earns money by selling equipment one unit at a time, while recurring revenue from follow-on services accounts for only about 4%. Once customers place fewer orders, performance can swing sharply.
In 2025, it delivered a record roughly 500 million euros in sales, which looked good on paper. But the profit earned that year did not truly turn into cash inflow. Free cash flow instead turned negative, with most of the money tied up in new plant expansion and inventory. Management itself has called 2026 a “transition year” and has already guided that both revenue and profit will decline. In niches such as bonding and photomasks, it does have some technical capabilities that are hard for others to dislodge. But those capabilities are narrow and deep, and they cannot shield the company from the broader industry cycle. Strong competitors are also targeting this attractive track and moving in.
Valuation is the part the report cares about most. Based on current profit, buying the whole company would take about 38 years to earn back the purchase price, which is on the expensive side for the equipment industry. According to the report’s calculations, even if everything goes smoothly for the company’s outlook, the current share price is already close to full value. It has effectively pulled forward many years of good news, leaving almost no margin to buy cheaply. The biggest risks to watch are concentrated customers, an industry cycle that can turn quickly, and powerful competitors. If the cycle weakens, a 50% drop in the share price is not impossible.
The report’s conclusion is that this is a “good company at a bad price.” It deserves a place on the watchlist for patient tracking, but now is not the time to buy. The above is only a plain-language explanation of this report and is not investment advice. The stock market involves risk; invest with caution.
LeadSÜSS MicroTec is a Germany-listed semiconductor equipment company focused on temporary bonding and debonding, UV exposure, coating and development tools for advanced packaging, plus photomask cleaning and handling systems. The core thesis is that AI chips and HBM create real long-term demand for its Advanced Backend Solutions business, but 2025's record €503.2 million in sales came with negative free cash flow and management defines 2026 as a transition year. Rating Watch: a quality cyclical business with credible niche barriers, but the current price already discounts too much future success.
Prices in the article are as of publication; see the valuation band above for the live price.
Conclusion First
| Item | View |
|---|---|
| Investment rating | Watch |
| Current price | €92.00, XETRA, timestamp 2026-06-09 09:33 |
| Does the current price offer a margin of safety | No |
| Suitable investor type | Growth or quality-oriented investors who can tolerate semiconductor equipment cycles and are willing to track the industry and order flow over the long term; less suitable for ordinary long-term investors who are balanced, conservative, and require a high margin of safety |
| Biggest uncertainties | The durability of the advanced packaging upcycle; whether the competitive landscape worsens because of hybrid bonding and the AI packaging chain; whether the 2030 margin targets can be delivered |
According to the company's IR page, the current share price of SUSS MicroTec SE is €92. Based on 19,115,538 shares outstanding disclosed in the annual report, the current market capitalization is about €1.76 billion. Using 2025 continuing operations EPS of €2.41, book value per share of €16.51, and sales per share of €26.35, the current share price implies roughly 38.2 times PE, 5.6 times PB, and 3.5 times PS. If enterprise value is estimated using 2025 year-end net cash of €49.1 million, it implies about 22.0 times EV/EBITDA and 25.9 times EV/EBIT. For a semiconductor equipment company whose revenue depends heavily on the capex cycle and whose service revenue share is still low, this valuation is not conservative for long-term investors.
My preliminary view is: this is an understandable, reasonably high-quality equipment business, but it is not a stable one. The company has certain barriers in several niche areas of advanced packaging and photomask handling, but these barriers look more like a narrow and deep technical moat than a wide moat that can fully smooth out cyclicality. In 2025, the company reached record sales of €503.2 million, but free cash flow turned negative. Management has also clearly defined 2026 as a "transition year," guiding for lower revenue and EBIT margin. At the same time, orders rebounded sharply in Q1 2026, which shows demand has not disappeared. The business is simply naturally volatile. For conservative long-term investors, the main issue is less that the company is poor, and more that the current price already reflects a lot of good news in advance.
If I think like a business owner with a horizon of more than 10 years rather than a share-price speculator, I am willing to keep studying and tracking this company. But if I had to buy today, I do not see enough margin of safety. More directly: it looks more like a good company at a bad price than a cheap good company.
Business Understanding and Industry Structure
SUSS MicroTec currently has two core operating segments. The first is Advanced Backend Solutions, which mainly includes mask aligners, UV projection scanners, temporary and permanent bonding, coating and development equipment. The second is Photomask Solutions, which mainly provides photomask cleaning and handling equipment. In its 2025 annual report, the company states that Advanced Backend Solutions accounts for about 70% of total group business, while the end markets it serves include advanced packaging, MEMS, and compound semiconductors. In other words, this is not a company that "sells chips." It sells chip manufacturing process equipment and solutions.
Its customers are mainly large international semiconductor manufacturers, foundries, photomask manufacturers, and research institutions. The company disclosed that in 2025, the group had two customers each contributing more than 10% of sales, at €112.2 million and €84.0 million respectively. Together, they accounted for about 39% of full-year revenue. Regionally, in 2025, 82.3% of sales came from Asia-Pacific, with Taiwan, South Korea, and China long serving as the most important markets. This shows that SUSS is close to the world's most advanced semiconductor capacity, but it also has meaningful customer and regional concentration.
The way the company makes money is not complicated. In essence, it sells equipment, upgrades, spare parts, and services. In the 2025 revenue mix, machine equipment sales were €443.4 million, upgrades were €10.6 million, spare parts were €27.5 million, and services were €21.5 million. In other words, pure service revenue accounted for only about 4.3%. Even if upgrades and spare parts are also treated as relatively recurring revenue, the combined share was only about 11.8%. This revenue structure matters because it tells us directly: SUSS is not a software-like business with high subscriptions, high maintenance revenue, and low volatility. It is still a capital goods business led by project-based equipment sales. This also explains why orders, backlog, and customer capex timing have a major impact on the income statement.
The cost structure of this business is also clear. Manufacturing, supply chain, R&D, installation, and on-site customer support are all heavy. In 2025, R&D expenses reached €47.0 million, about 9.3% of sales. Gross margin was 35.7%, and EBIT margin was 13.1%. In 2025, the gross margin and EBIT margin of the Advanced Backend Solutions segment fell markedly. The company attributed this to unfavorable changes in product and customer mix, additional ramp-up support for installed equipment, production ramp costs for new UV scanners, and inventory write-downs related to the termination of a non-strategic development project. The new Zhubei plant in Taiwan also raised costs. This explanation is broadly reasonable, but it again shows that SUSS's margins are not naturally smooth. Product mix and capacity utilization can materially change profitability.
From an industry perspective, I would classify it as a strongly cyclical equipment industry with structural growth. Growth comes from advanced packaging, HBM, AI modules, heterogeneous integration, and more complex photomask handling. Cyclicality comes from semiconductor conditions, customer expansion plans, regional policy, and technology transitions. In Q1 2026, the company disclosed that orders grew 69.5% year over year to €149.3 million, a new quarterly record. This was mainly driven by increased demand for solutions used in the AI chip module value chain and growth in orders for HBM-related bonding solutions. This direction is consistent with industry reality. The question is whether this demand can continue steadily, or whether it will be front-loaded and fade later, as has happened in many semiconductor equipment cycles.
If the stock market closed for 5 years, would I be willing to own this business? At the right price, yes. At the current price, no. I can understand this company. Its products are real. The customer and process barriers are not imaginary. But it is not the kind of stable cash cow that lets you sleep well without looking at it for years. It is more like a high-quality industrial technology business that requires continuous tracking of orders, product introductions, customer concentration, and cycle timing.
Business understandability score: 4/5. Industry attractiveness score: 3.5/5.
Moat Analysis
Using a Buffett-style framework, SUSS's moat does not come from a single source. It is a combination of several medium-strength barriers.
From the perspective of brand and technology position, the company says it has leading positions in several niches in temporary bonding and debonding and high-end photomask equipment, and that it aims to strengthen its competitive position through new products and more service revenue under its 2030 plan. In investor materials, management states clearly that "Photomask Equipment remains #1 in high-end segment" and "Temporary Bonding sustaining leadership, especially in HBM." But this needs an important qualification. These market share claims mainly come from the company itself and capital markets materials. Recent, complete, independent third-party verification is not sufficient, so I would treat them as evidence with some credibility but still requiring caution, not as ironclad proof.
From the perspective of switching costs and process qualification, SUSS's equipment is not a standard consumer product. After a customer introduces a tool into a production line, it often requires process parameter qualification, yield ramp-up, integration with upstream and downstream processes, on-site service, and long-term stability validation. This creates a certain level of switching cost, especially in yield-sensitive use cases such as advanced packaging, HBM-related bonding, and high-end photomask cleaning. The company's long-term cooperation with leading global fabs, photomask makers, and research institutions, and its view of R&D partners such as imec as important collaborators, show that it sells more than simple metal boxes. It sells a combination of equipment and process know-how.
From the perspective of cost and scale, SUSS is certainly not a super-scale company like ASML, but it has an installed base and engineering accumulation in its own niches. The issue is that this scale barrier is not yet strong enough to become an overwhelming advantage. One important piece of evidence is that system equipment still accounts for the absolute majority of 2025 revenue, while service and spare parts remain low as a share of sales. This means the installed base is growing, but the ability to repeatedly "collect rent" is not yet strong. The company itself lists a "strengthened service business" as one of its 2030 growth drivers, which indirectly shows that the moat is still being built rather than already wide.
From the perspective of network effects, data advantages, and channel advantages, I would not overstate them. SUSS is not a platform business, so network effects are basically absent. Its data advantage also does not compound the way connected equipment software might. It does have a global sales and service network, but that is more of a necessary condition than an independent deep moat. What matters more is technical matching capability in high-yield scenarios, customer qualification history, delivery experience, and on-site service capability.
The moat also faces external pressure. Advanced packaging and hybrid bonding are becoming high-value areas contested by semiconductor equipment giants. Reuters reporting over the past two years shows that BESI has a strong market position in hybrid bonding and has attracted a strategic investment from Applied Materials as well as M&A speculation. In 2026, BESI orders also benefited noticeably from hybrid bonding demand. This means the attractive track in which SUSS operates is also becoming more competitive. Good industries attract strong rivals.
Therefore, my view on the ten moat dimensions is as follows:
| Moat dimension | View |
|---|---|
| Brand advantage | Partly present |
| Cost advantage | Limited |
| Scale advantage | Moderate |
| Network effects | Basically none |
| Switching costs | Moderate to above moderate |
| Channel advantage | Moderate |
| Patents, licenses, and process barriers | Present |
| Data advantage | Limited |
| Corporate culture and operating capability | Some evidence |
| Capital allocation ability | Moderate, not outstanding |
Overall, I think SUSS's moat is in a stable to slightly widening phase, but it is nowhere near strong enough to ignore cycles and competition. It is more like a company with a reasonable chance of winning in a few key process steps than a company that can easily raise prices and steadily collect rent. In an inflationary environment, it may have some pricing power for high-end process equipment, but customer concentration, project-based bidding, and product mix volatility limit that pricing power. In a downturn, it may not necessarily lose money, but a sharp margin decline is entirely possible. The 2025 EBIT margin in Advanced Backend Solutions falling from 18.9% to 8.2% is already a real example.
Moat strength score: 3/5.
Management and Capital Allocation
My assessment of management is: professional, broadly candid, long-term oriented in direction, but not strongly aligned with shareholders through ownership. Capital allocation is rational, but not exceptional.
Start with the people. CEO Burkhardt Frick joined the management board in 2023. He previously worked for many years at ASML, covering supply chain, strategic cooperation, and market strategy. He also worked in semiconductor-related businesses at Philips. He understands the equipment industry and the Asian and US markets. In January 2026, the supervisory board extended his contract to the end of 2030. CFO Dr. Cornelia Ballwießer had her contract extended to mid-2028. This indicates that the supervisory board recognizes the current management team.
Next, candor. In October 2025, the company lowered its full-year gross margin and EBIT margin guidance through an ad hoc announcement. In March 2026, when it released the annual report, it clearly called 2026 a "transition year" and expected lower revenue and EBIT margin. For long-term investors, this willingness to discuss risk during a favorable period and to avoid hiding pressure on profits is a positive. Based on public information, management does not appear to be forcing a short-term narrative with excessive optimism.
In capital allocation, the most important move in 2025 was not buybacks or a large acquisition, but the construction and ramp-up of new capacity in Zhubei, Taiwan. This pushed 2025 capex up to €23.2 million, far above €7.6 million in 2024, and directly dragged free cash flow into negative territory. Whether it was worthwhile depends on whether this investment can translate into higher delivery capacity, better ability to serve large customers, and better margins in the coming years. Given the company's record orders in Q1 2026 and management's 2030 targets that are clearly above the current revenue base, the investment makes strategic sense. But from an owner perspective, the return on this capital has not yet been proven.
The company's shareholder return policy is generally restrained. Its dividend policy is to distribute 20% to 40% of free cash flow as dividends. Because free cash flow was under pressure in 2025, the proposed dividend fell from €0.30 per share in the previous year to €0.04 per share. This is more rational than forcing an unsustainable dividend. At the same time, the annual report shows that the company had no treasury shares at the end of either 2025 or 2024, and there was no sign of meaningful buybacks. So it has not bought back shares at high prices just to flatter EPS, which is also positive.
But if we judge whether interests are highly aligned with shareholders, management ownership is not high. At the end of 2025, the CEO held 5,184 shares, the CFO held 1,931 shares, and the COO held 3,927 shares. Relative to the company's 19.116 million total shares, this is very small. On incentives, the company's long-term equity incentives are linked to ROCE, sales growth, sustainability targets, and relative TSR. This is more reasonable than looking only at EPS, but it is still a professional manager incentive system rather than a structure where management itself is a major shareholder.
On the balance sheet, the company had net cash of €49.1 million at year-end 2025 and an equity ratio of 62.2%. In February 2026, it signed a new syndicated loan agreement totaling €115 million, replacing the previous €56 million facility to increase financial flexibility. For a cyclical equipment company, this financial structure is relatively solid. Its biggest risk is not financial leverage, but operating volatility and valuation.
Management and capital allocation score: 3/5.
Financial Quality and Owner Earnings
Start with the five-year financial profile. From 2021 to 2025, revenue increased from €263.4 million to €503.2 million, implying a four-year CAGR of about 17.6%. But margins and cash flow did not improve in a straight line. In 2025, gross margin was 35.7%, below 39.6% in 2024. EBIT margin was 13.1%, below 16.7% in 2024. Total free cash flow turned from €95.4 million in 2024 to -€26.0 million in 2025. One point deserves special attention: total free cash flow in the five-year overview includes the impact of discontinued operations, while free cash flow from continuing operations was €25.3 million in 2024 and -€22.6 million in 2025. If the basis is not distinguished, cash generation can easily be overstated.
| Year | Sales | Gross margin | EBIT margin | EBITDA | Net income from continuing operations | Total free cash flow | Capex | Net cash | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | 503.2 | 35.7% | 13.1% | 77.7 | 49.5 | -26.0 | 23.2 | 49.1 | 21.3% |
| 2024 | 446.7 | 39.6% | 16.7% | 82.4 | 51.7 | 95.4 | 7.6 | 122.9 | 36.8% |
| 2023 | 304.3 | 34.1% | 9.1% | 34.7 | 17.3 | 7.9 | 4.6 | 32.8 | 17.5% |
| 2022 | 260.0 | 38.7% | 12.1% | 37.4 | 23.3 | 17.0 | 4.1 | 41.3 | 23.6% |
| 2021 | 263.4 | 35.8% | 8.6% | 29.6 | 16.0 | 14.7 | 9.6 | 33.8 | 14.0% |
The key figures in the table come from the five-year overview in SUSS's 2025 annual report. The 2024, 2023, 2022, and 2021 figures are adjusted comparable figures noted by the company in the 2025 annual report.
Looking further at cash flow quality, several important facts stand out. First, accounting profit is not the same as distributable cash flow. In 2025, net income from continuing operations was €49.5 million, but operating cash flow from continuing operations was -€1.0 million. In 2024, operating cash flow from continuing operations was €32.6 million, and in 2023 it was €12.5 million. This shows that the match between profit and cash in this type of equipment company is highly affected by working capital swings.
Second, the core drag on 2025 cash flow was not debt interest, but working capital and expansion investment. Inventory fell from €210.7 million at year-end 2025 to €171.6 million, which appears to release cash. But accounts receivable rose to €37.8 million, accounts payable fell to €25.2 million, and more importantly, contract liabilities fell sharply from €96.2 million to €45.9 million. Contract liabilities are essentially customer prepayments and deferred revenue. A reduction in this source of "interest-free financing" can significantly hurt operating cash flow. In other words, weak 2025 cash flow does not mean the business collapsed. It shows that this business is highly sensitive to order execution timing and customer prepayments.
Third, the capital structure is broadly healthy. The equity ratio was 62.2% at year-end 2025. The company still had net cash and a low interest burden. In 2025, finance costs totaled €1.807 million, compared with €65.9 million of EBIT, so interest coverage was very high. From this perspective, SUSS's survival risk is not large. The real risk is that if demand falls or competition intensifies, margins and valuation multiples may compress at the same time.
Fourth, returns on capital are generally good, but volatile. The company's disclosed ROCE from 2021 to 2025 was 14.0%, 23.6%, 17.5%, 36.8%, and 21.3%. If ROE is roughly estimated using net income from continuing operations and average equity, 2024 was approximately 20%+, while 2025 fell back to the mid-teens. This shows that returns can be quite attractive in good years, but they are not stable. Over the long term, this looks more like a high-quality cyclical business with very high returns in upcycles and meaningful declines in downcycles than a consumer giant that reliably generates 20% ROIC year after year.
From the perspective of financial fraud or aggressive accounting, I currently do not see obvious red flags. The 2025 annual report received an unqualified audit opinion, and the company also states that it has consistently complied with the German Corporate Governance Code. But it is worth noting that the 2025 annual report retrospectively adjusted the 2024 and earlier figures, and the Q1 2026 press release also explains that comparable data were adjusted because of accounting policy changes. My interpretation is that this looks more like comparability issues caused by presentation and policy changes rather than obvious fraud. Still, for long-term time-series analysis, continuing operations and adjusted figures must be used.
Now consider Owner Earnings. Following the owner earnings approach, I would neither treat negative 2025 free cash flow as a permanent normal state nor treat the high 2024 free cash flow, which included discontinued operations disposal effects, as normal. A more reasonable conservative estimate is:
Net income from continuing operations: €49.5 million
Add back depreciation and amortization: €11.8 million
Deduct maintenance capex: I use a conservative estimate of €8 million, based on the fact that capex in 2021 to 2024 was mostly well below 2025, and that the elevated 2025 capex was mainly related to the new Taiwan plant expansion
Deduct normalized working capital needs: I conservatively estimate €10 million to €12 million, because this business is materially affected over time by swings in inventory, contract assets, and customer prepayments
On this basis, the company's conservative owner earnings in 2025 were roughly €40 million to €45 million. I prefer using €42 million as a conservative baseline. This level implies more than 40 times Owner Earnings at the current share price. For an equipment company with uneven cash flow, that is not cheap. The net income, depreciation, capex, and working capital judgments above are all based on data disclosed in the 2025 annual report.
My conclusion is: SUSS's profits are not fake profits, but they are also not naturally distributable cash profits. They are real industrial technology profits, but their volatility is amplified by cycles, prepayments, inventory, and expansion timing. Put differently, this company can make money over the long term, but the path of long-term profit generation will be bumpier than the income statement suggests.
Valuation and Margin of Safety
Owner Earnings Discount Model
I use three valuation scenarios, all starting from the 2026 transition year rather than linearly extrapolating from the strong 2025 revenue base. The reason is simple: management itself has guided 2026 revenue of €425 million to €485 million, gross margin of 35% to 37%, and EBIT margin of 8% to 10%, which means 2026 is not a high-growth operating year.
| Scenario | Key assumptions | Estimated intrinsic value per share |
|---|---|---|
| Conservative | 2026 owner earnings of €35m; 10-year CAGR of 6%; discount rate of 10%; terminal growth of 2.5%; add back 2025 year-end net cash | About €33/share |
| Base | 2026 owner earnings of €42m; 10-year CAGR of 9%; discount rate of 10%; terminal growth of 3%; add back net cash | About €49/share |
| Bull | 2026 owner earnings of €50m; 10-year CAGR of 12%; discount rate of 9%; terminal growth of 3.5%; add back net cash | About €87/share |
The starting points for these scenarios are as follows. The conservative case assumes only a mild recovery. The base case assumes the company can restore higher margins in the coming years and benefit from advanced packaging growth. The bull case is already clearly close to management's 2030 capital markets targets of "revenue of €750 million to €900 million, EBIT margin of 20% to 22%, free cash flow of about €90 million, and ROCE of 39% to 41%." In other words, the current share price is already almost close to my bull-case valuation result.
Relative Valuation Method
Using the current price and data from the company's 2025 annual report, SUSS currently trades at roughly 38.2 times PE, 5.6 times PB, 3.5 times PS, and 22.0 times EV/EBITDA. This is not a low valuation.
Judging from Reuters snapshot-style data, peers are also expensive: BESI's Reuters page shows a price statistic for "P/E excluding special items" of about 143 times, P/S of about 34.8 times, and P/B of about 47 times. Onto Innovation's Reuters page gives forward PE of about 33.6 times. Kulicke & Soffa's Reuters page gives ex-items PE of about 94.4 times, P/S of about 6.69 times, and P/B of about 5.99 times. These figures are extreme, but they illustrate the point: expensive peers do not make SUSS cheap. Moreover, these companies do not have identical business mixes. Some are more inspection-oriented, some more packaging-oriented, and some more bonding-oriented, so mechanical comparisons are not useful.
Here, I care more about a simple conclusion: SUSS is not currently trading at a cyclical-stock discount. It is trading at an advanced-packaging growth-stock premium. That is not friendly to conservative value investors.
Asset or Liquidation Value Method
The asset method has limited relevance for SUSS, but it can still provide a floor. At year-end 2025, the company had book value per share of €16.51 and net cash of €49.1 million, equal to about €2.57 per share. This means the current share price trades at a large premium to book value. The investment case must rest on sustained, high-quality cash generation over many years, not on cheap assets. If future growth and margins fail to materialize, the share price lacks a strong asset value floor.
Based on the three methods above, my valuation ranges are:
Conservative intrinsic value range: €30 to €40/share
Reasonable intrinsic value range: €45 to €60/share
Optimistic intrinsic value range: €75 to €90/share
At the current price of €92:
Relative to the conservative range: clear premium
Relative to the reasonable range: high premium
Relative to the optimistic range: roughly fair to slightly high
So my conclusion is:
Required margin of safety: at least 25% to 35%
Ideal buy price range: €35 to €50
Acceptable hold price range: €50 to €70
Clearly overvalued price range: above €80
Is the current price cheap enough: not cheap enough
From an expected return perspective, if one buys today at €92, my rough estimate of the next 10 years' annualized return is:
Conservative case: 4% to 5%
Base case: 5% to 7%
Bull case: 8% to 10%
For a single stock in a highly volatile industry like semiconductor equipment, this expected return is not enough to justify taking the risk of buying.
Risks, Comparisons, Checklist, and Final View
The most important risk is not a short-term share-price drawdown, but permanent capital loss. I would focus on the following points:
| Risk | Why it matters |
|---|---|
| Competition risk | Hybrid bonding and advanced packaging are attracting strong rivals such as BESI and Applied Materials. The better the track, the more intense the competition. |
| Technology substitution risk | If customer process roadmaps change, some equipment platforms may be marginalized. This often happens in semiconductor equipment. |
| Customer concentration risk | In 2025, the top two customers together accounted for about 39% of revenue. Any capex delay by either customer can materially affect results. |
| Regional and regulatory risk | In 2025, 82.3% of sales came from Asia-Pacific, and volatility in China orders has already affected the business. Geopolitics, export controls, and tariffs can all flow through to orders. |
| Cycle risk | 2025 sales reached a record high, but 2026 revenue and EBIT margin guidance is lower. That itself is evidence of equipment cyclicality. |
| Supply chain and execution risk | New capacity ramp-up, new product introductions, and service capability expansion can all bring cost overruns and gross margin volatility. |
| Valuation risk | The current valuation is already high. If growth or margins disappoint, multiple compression can directly impair long-term returns. |
| Accounting comparability risk | The 2025 annual report and Q1 2026 data retrospectively adjusted historical figures. This is not an obvious red flag, but it increases analytical error. |
The strongest bear case is actually quite forceful: SUSS may simply be in the right place during a small AI/HBM advanced packaging cycle, and the market may be treating it as a scarce high-growth equipment stock, while its real business structure remains project-based equipment, customer concentration, and volatile cash flow. If over the next few years the service revenue share does not rise, gross margin does not recover to management's target, and advanced packaging competition intensifies, the current valuation will look too optimistic. This bear case is not aggressive. I think it must be taken seriously.
What facts would make me admit the judgment was wrong and require a revaluation? There are five core points:
The order recovery proves to be only a short pulse: if orders and backlog in 2026 to 2027 cannot continue stepping up and instead fall after one strong quarter.
Long-term margin recovery fails: if after capacity expansion and product introductions, gross margin remains stuck in the mid-30% range and EBIT margin remains stuck in the low teens for a long time.
Service transition does not materialize: if services, spare parts, and upgrades remain almost unchanged as a share of revenue after several years, showing that cash flow resilience is still too weak.
Customer or technology share is lost: especially if stronger competitors take key projects in HBM, temporary bonding, and high-end photomask handling.
Cash flow remains weaker than profit for a long time: if free cash flow remains persistently below net income after the Taiwan expansion capex peak has passed.
Compared with other opportunities, my view is as follows. Compared with BESI, one of the strongest competitors, SUSS's valuation is indeed lower. But BESI has a stronger industry position in hybrid bonding, and the market is willing to give it a higher premium. SUSS's "cheapness" is relative, not absolute. Compared with broad indexes, global large-cap equities are still supported by strong earnings and AI capex. MSCI World-related ETFs have delivered about 78.28% cumulative return over the past 5 years, while the official S&P 500 page shows about 24.32% return over the past 1 year. To buy SUSS, one needs a clear basis for single-stock excess return, otherwise it may not beat a diversified index. Compared with low-risk assets, the German 10-year government bond yield is about 3.05%, which means conservative investors should demand expected returns significantly above that level before taking the operating and valuation risk of a single equipment stock. Based on my return estimate for SUSS at the current price, that compensation is not sufficient.
Investment Checklist
| Checklist item | Conclusion | Comment |
|---|---|---|
| Can I understand this business | Pass | Equipment and process solutions, with a clear logic. |
| Does it have stable long-term demand | Pass | Long-term demand exists, but the short and medium term are highly cyclical. |
| Does it have a durable moat | Uncertain | It has niche barriers, but not enough to fully resist competition and cycles. |
| Does it have pricing power | Uncertain | Some ability in high-end niches, but not strong overall. |
| Can it generate stable free cash flow | Fail | Cash flow is very sensitive to working capital and capex. |
| Are its returns on capital excellent | Pass | Excellent in good years, but volatile. |
| Is management trustworthy | Basically pass | Broadly candid and professional, but ownership is low. |
| Is capital allocation rational | Basically pass | Expansion and dividend policy are broadly rational. |
| Is the balance sheet solid | Pass | Net cash and a high equity ratio. |
| Is valuation below intrinsic value | Fail | The current price is above conservative and base-case valuation. |
| Is the margin of safety sufficient | Fail | Almost none. |
| Would I feel comfortable holding it long term | Uncertain | The business can be held, but the price is not comforting. |
| What key facts would make me sell | Listed | Share loss, weaker cash flow, failed margin recovery. |
| Am I buying only because of price momentum or emotion | Requires self-check | Advanced packaging and AI enthusiasm can easily inflate expectations. |
Open Questions and Data Limitations
This report requires three clear qualifications. First, regarding SUSS's "leading share" in several niche markets, recent and systematic independent third-party verification is incomplete. I can only cross-check the company's claims, public industry materials, and competitive news. Second, the 2025 annual report made retrospective adjustments to historical comparable data, so long-term cash flow and profit series should primarily be understood on a continuing operations basis. Third, because of limits in public snapshot data, some peer EV/EBITDA and ROIC data in the relative valuation are incomplete, so relative valuation is better for directional judgment than for precise anchoring.
Final Investment Conclusion
【Final Rating】 Watch
【One-Sentence Investment Thesis】 SUSS is a high-quality cyclical stock with certain technical barriers in advanced packaging and photomask equipment niches, but the current price has already pulled forward a lot of future success and lacks the margin of safety conservative investors should require.
【Core Bull Points】
The company sits in areas with long-term structural demand, including advanced packaging, HBM, and AI modules, and Q1 2026 orders reached a record high.
The balance sheet is solid, with net cash of €49.1 million at year-end 2025 and an equity ratio of 62.2%.
Management has semiconductor equipment experience. The CEO came from ASML, and the company has been relatively candid about the 2025 to 2026 pressure.
Niche products have a degree of process qualification barrier and customer stickiness, especially in high-end photomask and bonding applications.
If the 2030 plan is delivered, margins and free cash flow still have meaningful upside.
【Core Bear Points】
Revenue still depends heavily on equipment sales, service revenue is too low as a share of sales, and cash flow predictability is not strong.
Free cash flow from continuing operations was negative in 2025, and management has clearly guided 2026 as a transition year.
Customer and regional concentration are high. Asia-Pacific accounted for 82.3% of sales, and the top two customers together accounted for about 39% of revenue.
The track is attractive, but competitors are strong, especially in advanced packaging and hybrid bonding.
The current valuation lacks a margin of safety and is almost close to bull-case value.
【Key Assumptions】
AI/HBM-driven advanced packaging demand is not a short-term pulse, but lasts through at least several capex cycles.
The 2025 to 2026 capacity expansion and new product investment can translate into higher gross margin and free cash flow in the coming years.
The company does not suffer meaningful share loss at key customers.
Services, spare parts, and upgrades gradually rise as a share of revenue, improving cash flow quality.
【Fair Buy Price】 €35 to €50/share. This is based on the conservative to base intrinsic value range of €30 to €60/share, with an additional margin of safety of about 25% to 35%.
【Target Holding Period】 More than 10 years. The premise is buying at a price clearly below intrinsic value, not chasing an upcycle at a high-expectation valuation.
【Expected Annualized Return】 At the current price of about €92, my rough estimate is:
Conservative case: 4% to 5%
Base case: 5% to 7%
Bull case: 8% to 10% This return profile is not especially attractive for a volatile single stock.
【Maximum Loss Risk】 If the advanced packaging cycle rolls over, competition intensifies, margin recovery fails, and valuation de-rates, a share price returning to the €25 to €45 range is not unimaginable. That would imply a decline of about 50% to 73% from the current price. The company's intrayear low on XETRA in 2025 once reached €24.04, showing that the drawdown can be very large when market sentiment shifts.
【Tracking Indicators】
Order intake and backlog
Gross margin and EBIT margin of Advanced Backend Solutions
Revenue share from services, spare parts, and upgrades
APAC and China revenue/order share
Revenue share of the top two customers
Free cash flow and operating cash flow
Capex decline after the Taiwan expansion is completed
ROCE/estimated ROIC trend
New product introduction and customer qualification progress
Whether management continues to disclose candidly
【Signals That Trigger Reassessment】
Orders weaken for several consecutive quarters, and the order book fails to recover
Gross margin remains below 35% for a long time, and EBIT margin remains below 10% for a long time
Service transition does not improve, and cash flow keeps lagging profit
Key customer loss or major replacement by competitors at core process steps
Financial reporting bases continue to change frequently, further reducing comparability
Capex remains high but returns do not show up
【Final Recommendation】 Calmly put, SUSS is worth studying and belongs on a watchlist, but it is not yet worth forcing a bet with conservative long-term capital. If your preference is to buy good businesses at reasonable or cheap prices, I would keep tracking rather than chase the price. What makes long-term returns more robust is not only finding a decent company, but also keeping decent price discipline even when the company is decent.
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free